Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;56(2):188-203.
doi: 10.3947/ic.2023.0072.

Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition

Won Suk Choi  1 , Joon Young Song  1 , Ki Tae Kwon  2 , Hyo-Jin Lee  3 , Eun Ju Choo  4 , Jihyeon Baek  5 , BumSik Chin  6 , Woo Joo Kim  1 , Mi Suk Lee  7 , Wan Beom Park  8 , Sang Hoon Han  9 , Jun Yong Choi  9 , Joon Sup Yeom  9 , Jin-Soo Lee  5 , Hee-Jung Choi  10 , Young Hwa Choi  11 , Dong-Gun Lee  3 , Jung-Hyun Choi  3 , Hee Jin Cheong  12 ; Committee of Adult Immunization; Korean Society of Infectious Diseases
Affiliations
Review

Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition

Won Suk Choi et al. Infect Chemother. 2024 Jun.

Abstract

The Korean Society of Infectious Diseases has been regularly developing guidelines for adult immunization since 2007. In 2023, the guidelines for the following seven vaccines were revised: influenza, herpes zoster, pneumococcal, tetanus-diphtheria-pertussis (Tdap), human papillomavirus (HPV), meningococcal, and rabies vaccines. For the influenza vaccine, a recommendation for enhanced vaccines for the elderly was added. For the herpes zoster vaccine, a recommendation for the recombinant zoster vaccine was added. For the pneumococcal vaccine, the current status of the 15-valent pneumococcal conjugate vaccine and 20-valent PCV was described. For the Tdap vaccine, the possibility of using Tdap instead of tetanus-diphtheria vaccine was described. For the HPV vaccine, the expansion of the eligible age for vaccination was described. For the meningococcal vaccine, a recommendation for the meningococcal B vaccine was added. For the rabies vaccine, the number of pre-exposure prophylaxis doses was changed. This manuscript documents the summary and rationale of the revisions for the seven vaccines. For the vaccines not mentioned in this manuscript, the recommendations in the 3rd edition of the Vaccinations for Adults textbook shall remain in effect.

Keywords: Adult; Guideline; Immunization; Korea; Vaccination.

PubMed Disclaimer

Conflict of interest statement

HJC, JYS, JYC, HJC are editorial board, WBP is associate editor, DGL is editor-in-chief of Infect Chemother; however, they did not involve in the peer reviewer selection, evaluation, and decision process of this article. Otherwise, no potential conflicts of interest relevant to this article was reported.

References

    1. Choi WS, Choi JH, Kwon KT, Seo K, Kim MA, Lee SO, Hong YJ, Lee JS, Song JY, Bang JH, Choi HJ, Choi YH, Lee DG, Cheong HJ Committee of Adult Immunization; Korean Society of Infectious Diseases. Revised adult immunization guideline recommended by the Korean Society of Infectious Diseases, 2014. Infect Chemother. 2015;47:68–79. - PMC - PubMed
    1. Domnich A, de Waure C. Comparative effectiveness of adjuvanted versus high-dose seasonal influenza vaccines for older adults: a systematic review and meta-analysis. Int J Infect Dis. 2022;122:855–863. - PubMed
    1. Jackson ML. Influenza vaccine effectiveness in elderly people. Lancet Infect Dis. 2014;14:1169–1170. - PubMed
    1. Chang LJ, Meng Y, Janosczyk H, Landolfi V, Talbot HK QHD00013 Study Group. Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65\xe2\x80\xafyears of age: a phase 3 randomized clinical trial. Vaccine. 2019;37:5825–5834. - PubMed
    1. Essink B, Fierro C, Rosen J, Figueroa AL, Zhang B, Verhoeven C, Edelman J, Smolenov I. Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults. Vaccine. 2020;38:242–250. - PubMed